WCG
RMD icon

Weaver Consulting Group’s ResMed RMD Stock Holding History

Weaver Consulting Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-40
Closed -$7K – 718
2020
Q3 		$7K Hold
40
– – ﹤0.01% 637
2020
Q2 		$8K Hold
40
– – ﹤0.01% 579
2020
Q1 		$6K Hold
40
– – ﹤0.01% 537
2019
Q4 		$5K Hold
40
– – ﹤0.01% 620
2019
Q3 		$5K Hold
40
– – ﹤0.01% 605
2019
Q2 		$5K Hold
40
– – ﹤0.01% 587
2019
Q1 		$5K Buy
+40
New +$4.13K ﹤0.01% 1116

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weaver Consulting Group's RMD Position: Q4 2020 in Review

Weaver Consulting Group sold out of ResMed (RMD) in Q4 2020, closing a stake of 40 shares — an estimated $7K sold.

Weaver Consulting Group first reported a position in RMD in Q1 2019 and held it in 7 quarters. The position peaked at $8K in Q2 2020. 663 funds tracked by Wall St. Rank hold RMD as of Q4 2020.

  • Weaver Consulting Group reported no remaining ResMed position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 40 ResMed shares in Q4 2020, an estimated $7K.
  • Weaver Consulting Group first reported a position in ResMed in Q1 2019 and held it in 7 quarters.
  • Weaver Consulting Group's ResMed position peaked at $8K in Q2 2020.
  • 663 funds tracked by Wall St. Rank held ResMed as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.